SureTrader SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Benitec Biopharma Ltd. ADR (BNTC)

BNTC RSS Feed
Add BNTC Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 1/18/2017 10:16:04 AM - Followers: 40 - Board type: Free - Posts Today: 0

Silencing Genes For Life™
 




ASX:BLT
NASDAQ: BNTC
                                                                                                                                                    

HOME PAGE
 
 
ANNUAL REPORTS
 
 
ANALYSTS
 
 
REUTERS BLT.AX
 
 
YAHOO CHART
 
ddRNAi: expressed RNA interference technology
ddRNAi (DNA-directed RNAi) is a unique platform technology for silencing unwanted or disease-causing genes. In the context of therapy, ddRNAi avoids many of the drawbacks of other gene silencing technologies and produces much longer-lasting effects. Benitec Biopharma pioneered ddRNAi and was the first company to demonstrate expressed RNAi in human cells. We hold a dominant intellectual property position in RNAi, with over 40 issued global patents for the human use of ddRNAi. Learn how ddRNAi could target countless human and viral genes. Track our pipeline programs using this exciting technology. View the scope of our patents in ddRNAi. Join us in developing transformational solutions for human health.

Pipeline for ddRNAi gene silencing

Benitec Biopharma’s pipeline of in-house and partnered programs to develop therapeutics for chronic and life-threatening conditions is based on our proprietary technology, DNA-directed RNA(ddRNAi). View our out-licensed programs  

Due to its demonstrated ability to effect long-lasting gene silencing, once proven in human trials, ddRNAi technology has significant potential to treat or cure a broad range of human diseases and conditions. These include cancers, neurological diseases, infectious diseases, autoimmune diseases, genetic diseases and other afflictions that are associated with the expression of a small number of key genes.



Our in-house pipeline is summarized below,  In-house pipeline

. View our out-licensed programs  Out-licensed programs Successful development of therapeutic products in just one of these programs would be a major breakthrough in medical therapy.

 

 

Expressed RNAi for lasting treatment or cure

Tacere Therapeutics develops human therapeutics based on RNA interference (RNAi)  and ddRNAi gene-silencing technology from Benitec Biopharma. Using this approach, the drugs we create promise long term treatment or cure with a single dose.

We target human diseases for which there is currently no effective treatment.  Our pipeline includes drugs for Hepatitis C and Age-Related Macular Degeneration.

Tacere Therapeutics is a Benitec Biopharma company.


http://www.tacerebio.com/index.htm
 


Summary
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BNTC
Current Price
Volume:
Bid Ask Day's Range
SureTrader
BNTC News: Report of Foreign Issuer (6-k) 01/17/2017 06:20:02 AM
BNTC News: Benitec Receives Orphan Drug Designation in the European Union for BB-301, a ddRNAi Therapeutic in Development for the Treatm... 01/17/2017 05:00:00 AM
BNTC News: Amended Statement of Ownership (sc 13g/a) 01/09/2017 01:29:12 PM
BNTC News: Report of Foreign Issuer (6-k) 12/23/2016 06:03:21 AM
BNTC News: Benitec in-licenses clinical program for head and neck cancer from NantWorks 12/23/2016 06:00:00 AM
PostSubject
#2052   Today certainly isn't awesome. The pps action sucks. retireat40 01/18/17 10:16:04 AM
#2051   Awesome... Peacefulwendy 01/18/17 09:13:47 AM
#2050   Awesome... Peacefulwendy 01/18/17 09:13:45 AM
#2049   Wow. AH trading back into the $2.80's. A retireat40 01/17/17 08:03:10 PM
#2048   Thanks Wendy! A lot has been going Blane 01/17/17 07:23:57 PM
#2047   * * $BNTC Video Chart 01-17-17 * * ClayTrader 01/17/17 05:16:44 PM
#2046   Huge EOD sell off. We'll see what happens retireat40 01/17/17 04:04:47 PM
#2045   I need help as I am not a saster 01/17/17 02:46:54 PM
#2044   BNTC has another major catalyst gas approaching Jan cashcow3 01/17/17 01:12:05 PM
#2043   $ 10 billion market.. cashcow3 01/17/17 12:54:21 PM
#2042   http://www.ariva.de/news/benitec-receives-orphan-drug-designation-in-the-europea cashcow3 01/17/17 12:53:52 PM
#2041   3.95 again this want higher......... cashcow3 01/17/17 12:44:59 PM
#2040   and no one has understood what is happening cashcow3 01/17/17 12:43:03 PM
#2038   these shorts are getting screwed haha cashcow3 01/17/17 12:42:05 PM
#2037   ... $ 4.5 eod SQEEZE................... cashcow3 01/17/17 12:35:07 PM
#2036   huge news ..this is great.. cashcow3 01/17/17 12:34:17 PM
#2035   Happy 4 U! Peacefulwendy 01/17/17 11:59:28 AM
#2034   In 2.25 pre market and out at 4.13 867moneytime 01/17/17 09:59:33 AM
#2033   Could be huge runner. On watch. 867moneytime 01/17/17 07:41:10 AM
#2032   Benitec get EU approval for orphan drugs status Blane 01/16/17 11:25:27 PM
#2031   PRIVATE PLACEMENT IN Franyeld 10/24/16 07:50:56 PM
#2030   This is a very significant strategic Franyeld 10/24/16 07:46:11 PM
#2029   Strategic Engagement with NantVentures (Soon-Shiong)! http://blt.live.irmau.com/ Blane 10/24/16 04:44:40 PM
#2028   Thanks,Wendy! Same to you! Blane 10/12/16 08:26:34 PM
#2027   I will. Thanks for the update. Peacefulwendy 10/12/16 11:45:35 AM
#2026   Yes, thanks, Wendy! Hope all is well Blane 10/11/16 04:02:16 PM
#2025   Hey Blane. Hope all is well. Peacefulwendy 10/03/16 11:30:51 AM
#2024   Quarterly Report and conference Call. Blane 08/31/16 02:53:45 PM
#2023   Change up with senior management team announced. Blane 08/10/16 01:48:03 PM
#2022   Anyone notice the ask is $2.50? Strange. Blane 07/09/16 09:37:13 AM
#2021   The latest as of Tuesday, May 24, 2016 georgejjl 05/24/16 10:00:11 PM
#2020   Benitec to host LIVE corporate conference call on Blane 05/17/16 05:48:54 AM
#2019   Benitec releases impressive OPMD in-vivo data! http://www.benitec.com/documents/ Blane 04/19/16 12:58:30 AM
#2018   Attention all BNTC shareholders, a poster on the Blane 03/27/16 08:26:49 PM
#2017   It is a complete disaster and will survive Analogman 03/09/16 11:31:07 AM
#2016   Benitec releases positive in-vivo HBV data. http://blt.live.irmau.com/IRM/PDF/16 Blane 03/08/16 03:55:24 PM
#2015   Benitec Due Diligence – March 1, 2016 Blane 03/01/16 02:44:27 PM
#2014   Seems so. But at least all the Blane 02/25/16 07:03:14 PM
#2013   The demise of TT-034 was a foregone conclusion: DewDiligence 02/25/16 07:01:29 PM
#2012   HCV trial stopped to pursue other indications. HCV Blane 02/25/16 06:38:49 PM
#2011   Despite where the company is at the moment, Blane 02/11/16 12:28:06 PM
#2010   General Electric is interested in Calimmune georgejjl 01/10/16 03:52:26 PM
#2009   Panno speaks on what data and a new Blane 01/04/16 09:50:38 AM
#2008   $BNTC recent news/filings stocktrademan 12/17/15 03:40:44 PM
#2007   I must apologize. It reads Tues/Wed. So on Blane 12/12/15 04:35:00 PM
#2006   I must apologize. It reads Tues/Wed. Blane 12/12/15 04:31:49 PM
#2005   If you're in the US, yes, it is Blane 12/12/15 03:47:05 PM
#2004   Well, to be frank, there's actually no clear Blane 12/12/15 03:16:58 PM
#2003   Why was the CEO pushed out? DewDiligence 12/09/15 08:31:58 PM
#2002   Benitec announces positive HBV preclinical data! http://blt.live.irmau.com/IRM/P Blane 12/07/15 01:40:33 AM
PostSubject